Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Insmed (INSM) Equity Ratio (2016 - 2026)

Insmed's Equity Ratio history spans 17 years, with the latest figure at 0.34 for Q1 2026.

  • Quarterly Equity Ratio rose 517.3% to 0.34 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.34 through Mar 2026, up 517.3% year-over-year, with the annual reading at 0.33 for FY2025, 131.58% up from the prior year.
  • Equity Ratio came in at 0.34 for Q1 2026, up from 0.33 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.5 in Q2 2025 to a low of 0.4 in Q1 2024.
  • The 5-year median for Equity Ratio is 0.05 (2022), against an average of 0.07.
  • Year-over-year, Equity Ratio crashed 1263.0% in 2024 and then skyrocketed 2249.98% in 2025.
  • Insmed's Equity Ratio stood at 0.05 in 2022, then plummeted by 570.08% to 0.25 in 2023, then soared by 156.46% to 0.14 in 2024, then skyrocketed by 131.58% to 0.33 in 2025, then grew by 4.05% to 0.34 in 2026.
  • Per Business Quant, the three most recent readings for INSM's Equity Ratio are 0.34 (Q1 2026), 0.33 (Q4 2025), and 0.4 (Q3 2025).